FIELD: medicine.
SUBSTANCE: method involves administering non-prolonged action Carbamazepin at a dose of 30-50 mg in cases of children younger then 10, at a dose of 50-100 mg in cases of persons older than 50 before going to sleep. Glycin, angiotropic preparations selected from group: Vinpocetin, Pentoxifillin, Gingo Biloba and L-carnitine preparations are additionally given in therapeutic doses before noon. The total continuous treatment course is 3 months to 3 years long. Persons of marked mental insufficiency older than 8, additionally receive preparations of L-DOFA + Carbidopa at a dose of 30-60 mg of L-DOFA once a day in the morning.
EFFECT: preparation is applicable for long time (several years); no psychophysical addiction observed.
2 cl, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING DISTURBED NEUROPSYCHIC DEVELOPMENT OF CHILDHOOD | 2012 |
|
RU2505293C1 |
| METHOD OF TREATING EPILEPSIAS | 2013 |
|
RU2548712C2 |
| METHOD FOR CORRECTION OF DISTURBED NEUROPSYCHIC STATE IN CHILDREN WITH REACTIVE ASTHENIC SYNDROME | 2023 |
|
RU2815894C2 |
| L-TRYPTOPHAN PREPARATION CONTAINING CARBIDOPA/BENSERAZIDE | 2005 |
|
RU2377983C2 |
| METHOD FOR TREATING DISCIRCULATORY ENCEPHALOPATHY | 2003 |
|
RU2242989C2 |
| REMEDY FOR TREATING CENTRAL-GENESIS AMENORRHEA | 1999 |
|
RU2145848C1 |
| COMBINED REMEDY FOR IMPROVING THE FUNCTIONAL STATE OF THE BRAIN | 2021 |
|
RU2782672C1 |
| NOVEL NUTRACEUTICAL COMPOSITIONS CONTAINING STEVIA EXTRACT OR STEVIA EXTRACT COMPONENTS AND USES THEREOF | 2008 |
|
RU2519718C2 |
| COMBINED DRUG PREPARATION | 2011 |
|
RU2500415C2 |
| APPLICATION OF BETA-HYDROXYBUTYRATE OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR PREPARATION OF MEDICATION WHICH POSSESSES CYTOPROTECTIVE ACTIVITY, INCLUDING NEUROPROTECTIVE, CARDIOPROTECTIVE, ANTI-ISCHEMIC, ANTI-HYPOXIC, ANTI-STRESS, ACTOPROTECTIVE AND ADAPTOGENIC ACTIVITY, MEDICATION AND METHOD OF PREVENTION, RELIEF AND TREATMENT BY MEANS OF SAID MEDICATION | 2009 |
|
RU2426535C2 |
